Top news of the week: 08.12.2021.
Startups
Meet The VCs Having Twice The Fun In Half The Time
VC firm Operator Partners, founded by Flatiron Partners' Nat Turner and Zach Weinberg, has invested in more than 100 startups to date, from mental health unicorn Spring Health to NBA Top ...
A serial biotech entrepreneur launches his next startup with high-dollar backing
Founded and led by Gary Glick, Odyssey Therapeutics has raised $218 million in an initial fundraising round for its cancer and inflammatory disease drug research.
Apple Tree Partners breaks into UK with biotech Adendra Therapeutics launch, $53M series A raise
Apple Tree Partners has picked its first U.K.-based venture to launch: Adendra Therapeutics, an immunotherapy company focused on dendritic cell biology to treat cancers and autoimmune ...
'We're getting there': LGBTQ+ progress in biotech lingers in the 'diagnose' stage
The biotech industry is "getting there" in terms of advancing LGBTQ+ inclusion, but it's an effort that remains in the early innings. Fierce Biotech spoke with more than 20 LGBTQ+ leaders ...
Little European biotech Sotio nabs a super $316M funding round for its superagonist work
In one of the biggest funding rounds for a European biotech ever, Czech Republic cancer company Sotio Biotech has grabbed a huge 280 million euro ($316 million) raise.
Tune Therapeutics' epigenetic platform resonates with investors as it snags $40M in financing
More dollars are flowing into the epigenome, with multiple VC shops backing new biotech Tune Therapeutics with $40 million to dial up or turn down gene expression. The North Carolina and ...
Opinion: Biden risks killing his cancer moonshot on the launchpad
Drug-pricing caps in the the president’s Build Back Better Act would destroy financial incentives for innovation.
Anne Wojcicki’s 23andMe Fortune Falls Under $1 Billion As Shares Sink Post-IPO
Her genetics testing company is the latest to flounder after going public via SPAC.